SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CVTX - CV Therapeutics, Inc.
An SI Board Since January 1999
Posts SubjectMarks Bans
411 31 0
Emcee:  Todd N. Weisrock Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
261CV Therapeutics (CVTX) Cowen Eric Schmidt Opinion: Neutral week change: -12%mopgcw-5/23/2006
260CV Therapeutics Announces Abstract to Be Presented at Heart Rhythm 2006 Scientifmopgcw-5/6/2006
259mstar: Analyst Note 04-26-06 CV Therapeutics reported first-quarter results Tuemopgcw-4/29/2006
258CV Therapeutics Secures Three Year Equity Financing Commitment Tuesday April 18,mopgcw-4/18/2006
257CV Therapeutics Launches Ranexa Friday March 24, 7:00 am ET First New Pharmacemopgcw-3/25/2006
256citi CVTX: Physician Checks At ACC Reveal Modest Awaress of Ranexa mopgcw-3/18/2006
255forbes: CV Therapeutics' Ranexa May Have Trouble Meeting Street Targets Petemopgcw-3/9/2006
254Citigroup; CVTX: Q4 Uneventful, Setting Stage for Ranexa Launch mopgcw-3/6/2006
253CV Therapeutics Reports 2005 Fourth Quarter and Full Year Financial Results 4:03mopgcw-3/6/2006
252CV Therapeutics Announces Four Abstracts Accepted for Presentation at American Cmopgcw-3/6/2006
251Any analyst reports on the earnings? Taken a hit since earnings... Bbball-3/3/2006
250citi: CVTX: Cardiologists Note That Ranexa Will Be Niche Drug, As Expectemopgcw-2/27/2006
249What does everyone make of the announcement this week? Is it just confirming inKaiserSosze-2/11/2006
248mopgcw...thank you for the posts from the brokerages.....bball-2/1/2006
247piper: KEY POINTS: * Ranexa Receives Favorable Label " No Black Box Warninmopgcw-2/1/2006
246CVTX :Ranexa Approved with Favorable Label; Reiterate Buy Ratin 2006-01-30 07:57mopgcw-2/1/2006
245piper: KEY POINTS: * Providing Balance Around Ranexa Comments. We hosted a callmopgcw-2/1/2006
244m-star: CV Therapeutics CVTX announced Friday that the Food and Drug Administramopgcw-1/30/2006
243Update 2-CV Therapeutics says heart drug gets FDA nod Fri Jan 27, 2006 08:31 PM LJM-1/27/2006
242FDA Approves Ranexa Friday January 27, 5:14 pm ET Conference Call on Sunday, Jmopgcw-1/27/2006
241Citi: CVTX: Merlin's Outcome is Key to Future Success mopgcw-1/17/2006
240Citicorp out with a Hold today. Any info? TIA & Cheers, Tucktuck-1/17/2006
239waiting to hear: January 27, 2006: Ranexa PDUFA date for refractory chronic anmopgcw-1/7/2006
238ERICA results from AHA: >>DALLAS, Nov. 16 /PRNewswire-FirstCall/ -- CV Thtuck-11/16/2005
237CV Therapeutics Announces Presentations at American Heart Association Scientificmopgcw-11/5/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News